T.F. Patterson

Discipline

Economies et finances (1)

Type de document

Articles (5) Recensions (3)

Co-auteur

J. Maertens

T. Calandra

P.G. Pappas

O. Lortholary

B.J. Kullberg

R Herbrecht

J.R. Wingard

J. Wauters

T.J. Walsh

C. Viscoli

P.E. Verweij

F.L. van de Veerdonk

D.A. Stevens

B.H. Segal

J.A. Schouten

T.R. Rogers

BJA Rijnders

J.R. Perfect

M.H. Nguyen

I. Martin-Loeches

R.E. Lewis

C. Lass-Flörl

K. Lagrou

C.A. Kauffman

J.P. Donnelly

W.E. Dismukes

P. Depuydt

O.A. Cornely

C.J. Clancy

T. Chiller

RJM Brüggemann

S. Blot

J. Bille

J.E. Bennett

M. Bassetti

E. Azoulay

T. Zaoutis

L.J. Wheat

M.A. Viviani

L. Vanderbeke

I. Spriet

T.C. Sorrell

J.D. Sobel

J. Sobel

M.A. Slavin

H.T. Schlamm

M. Ruhnke

A. Rodriguez

A. Restrepo

L. Ostrosky-Zeichner

F.C. Odds

P. Muñoz

G. Maschmeyer

K.A. Marr

O. Marchetti

P.W. Liu

P.L. Liu

D.P. Kontoyiannis

P. Koehler

C.C. Kibbler

E.M. Johnson

NAF Janssen

W.W. Hope

S.M. Holland

J.R. Graybill

W. Graninger

D.R. Giacobbe

J.E. Edwards

B. Dupont

D.W. Denning

B.E. De Pauw

B. de Pauw

D. de Lange

C. Cordonnier

J.B. Buil

E. J. Bow

L.R. Baden

N.G. Almyroudis

Date

Source

Serveur académique Lausannois (5)

Mot-clé

Patients (5) Patients (5) recherche (4) maladie (4) Treatment (4) Aspergillus (4) Research (4) Mycoses (4) Human beings (4) Research (4) maladie (4) thérapie (3) mortalité (3) Mortality (3) Aspergillosis (3) Therapeutics (3) Serum (3) Organization (3) Mortality (3) Manufacturers' agents (3) Commission merchants (3) Organization (3) norme (2) besoin (2) gestion (2) épidémiologie (2) classification (2) cancer (2) Epidemiology (2) Diagnosis (2)

Documents écrit par T.F. Patterson (5) | parle de T.F. Patterson (1)

Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis.

P.E. Verweij et al.

Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion.

P.E. Verweij et al.

Application of the 2008 definitions for invasive fungal diseases to the trial comparing voriconazole versus amphotericin B for therapy of invasive aspergillosis: a collaborative study of the Mycoses Study Group (MSG 05) and the European Organization for Research and Treatment of Cancer Infectious Diseases Group.

R. Herbrecht et al. (2015)

Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.

B. De Pauw et al. (2008)

Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria.

B.H. Segal et al. (2008)